Literature DB >> 23335301

Examining factors that influence erroneous phosphorylation site localization via competing fragmentation and rearrangement reactions during ion trap CID-MS/MS and -MS(3.).

Li Cui1, Gavin E Reid.   

Abstract

Factors influencing the magnitude of competing fragmentation and intramolecular phosphate group rearrangement reactions during CID-MS/MS and CID-MS(3) of protonated phosphopeptide ions in ion trap mass spectrometers, and their effect on phosphorylation site localization using automated search algorithms, have been examined by systematically varying the peptide composition, the identity, number, and position of the phosphorylated "donor" and nonphosphorylated "acceptor" residues, and the proton mobility of the precursor ion charge states for a synthetic phosphopeptide library. CID-MS(3) of product ions formed via combined neutral losses of HPO3 and H2 O, rather than direct loss of H3 PO4 from phosphotyrosine containing peptides yielded incorrect phosphorylation site assignments, while correct phosphorylation site assignments for phosphothreonine and phosphoserine containing peptides were highly dependant on the relative abundance of these competing fragmentation pathways. Abundant phosphate group rearrangement product ions were observed from CID-MS/MS of multiply protonated phosphopeptide ions, with increased rearrangement under nonmobile or partially mobile protonation conditions, and as a function of the identity and number of the donor and acceptor residues. A clear inverse trend was observed between the amplitude of these rearrangement reactions and the confidence for phosphorylation site localization, and rearrangement played a contributing role in erroneous phosphorylation site assignment for several peptides.
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23335301     DOI: 10.1002/pmic.201200384

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  8 in total

1.  Large-Scale Examination of Factors Influencing Phosphopeptide Neutral Loss during Collision Induced Dissociation.

Authors:  Robert Brown; Scott A Stuart; Scott S Stuart; Stephane Houel; Natalie G Ahn; William M Old
Journal:  J Am Soc Mass Spectrom       Date:  2015-04-08       Impact factor: 3.109

2.  Gas-phase intermolecular phosphate transfer within a phosphohistidine phosphopeptide dimer.

Authors:  Maria-Belen Gonzalez-Sanchez; Francesco Lanucara; Gemma E Hardman; Claire E Eyers
Journal:  Int J Mass Spectrom       Date:  2014-06-15       Impact factor: 1.986

3.  Label scrambling during CID of covalently labeled peptide ions.

Authors:  Nicholas B Borotto; Nicholas Degraan-Weber; Yuping Zhou; Richard W Vachet
Journal:  J Am Soc Mass Spectrom       Date:  2014-07-24       Impact factor: 3.109

4.  193 nm Ultraviolet Photodissociation Mass Spectrometry for Phosphopeptide Characterization in the Positive and Negative Ion Modes.

Authors:  Michelle R Robinson; Juliana M Taliaferro; Kevin N Dalby; Jennifer S Brodbelt
Journal:  J Proteome Res       Date:  2016-07-26       Impact factor: 4.466

5.  Quantification of competing H3PO4 versus HPO3 + H2O neutral losses from regioselective 18O-labeled phosphopeptides.

Authors:  Li Cui; Ipek Yapici; Babak Borhan; Gavin E Reid
Journal:  J Am Soc Mass Spectrom       Date:  2013-11-19       Impact factor: 3.109

Review 6.  Phosphoproteomics in the Age of Rapid and Deep Proteome Profiling.

Authors:  Nicholas M Riley; Joshua J Coon
Journal:  Anal Chem       Date:  2015-11-19       Impact factor: 6.986

Review 7.  Phosphopeptide Fragmentation and Site Localization by Mass Spectrometry: An Update.

Authors:  Clement M Potel; Simone Lemeer; Albert J R Heck
Journal:  Anal Chem       Date:  2018-12-05       Impact factor: 6.986

8.  Strong anion exchange-mediated phosphoproteomics reveals extensive human non-canonical phosphorylation.

Authors:  Gemma Hardman; Simon Perkins; Philip J Brownridge; Christopher J Clarke; Dominic P Byrne; Amy E Campbell; Anton Kalyuzhnyy; Ashleigh Myall; Patrick A Eyers; Andrew R Jones; Claire E Eyers
Journal:  EMBO J       Date:  2019-08-21       Impact factor: 11.598

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.